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ABSTRACT
Influenza viruses with truncated NS1 protein stimulate a more intensive innate immune response compared to their wild type 
counterparts. Here, we investigate how the shortening of the NS1 protein influence the immunogenicity of the conserved T-cel-
lular epitopes of influenza virus. Using flow cytometry, we showed that the intraperitoneal immunization of mice with influenza 
virus encoding 124 N-terminal amino acid residues of the NS1 protein (A/PR8/NS124) induced higher levels of CD8+ T-cells recog-
nizing immunodominant (NP366-374) and sub-immunodominant (NP161-175, NP196-210, HA323-337, HA474-483, NA427-433) epitopes compared to 
immunization with the virus expressing full-length NS1 (A/PR8/full NS). It is noteworthy that the response to the immunodomi-
nant influenza epitope NP366-374 was achieved with the lower immunization dose of A/PR8/NS124 virus compared to the reference 
wild type strain. Despite the fact that polyfunctional CD8+ effector memory T-lymphocytes simultaneously producing two (IFNγ 
and TNFα) or three (IFNγ, IL2, and TNFα) cytokines prevailed in the immune response to both viruses, the relative number of such 
T-cells was higher in A/PR8/NS124-immunized mice. Furthermore, we have found that polyfunctional populations of lymphocytes 
generated upon the immunization of mice with the mutant virus demonstrated an increased capacity to produce IFNγ compared 
to the corresponding populations derived from the A/PR8/full NS-immunized mice. Therefore, immunization with the attenuated 
influenza virus encoding truncated NS1 protein ensures a more potent CD8+ T-cell immune response.  
INTRODUCTION
According to meta-analysis [1], the effectiveness of mod-
ern influenza vaccines in people aged 18-65  years is 
about 60%. Inactivated vaccines mostly induce a humoral 
immune response and effective protection only when the 
antigenic structure of surface influenza proteins in vac-
cine strains coincides with the antigenic structure of sur-
face proteins of circulating viruses [2]. Live attenuated 
influenza vaccines (LAIVs) induce not only humoral but 
also mucosal and T-cellular immunity. The ability of LAIV 
strains to replicate in the upper respiratory tract provides 
a way to trigger the MHC-I/II-dependent presentation of 
conserved epitopes to CD8+ and CD4+ T-cells. It has been 
shown in recent studies that circulating influenza viruses 
of types A, B, and C share common CD8+ T-cellular epit-
opes that could induce the cross-protective immune re-
sponse [3]. Memory CD8+ T-cells directed against these 
universal epitopes were found in the blood and lungs of 
healthy humans [3]. Despite the existence of such highly 
conserved cross-protective influenza epitopes, the T-cel-
lular immune response induced by LAIVs is insufficient 
to provide a broad cross-protection [4]. It is noteworthy 
that all of the licensed LAIVs contain viruses compris-
ing active NS1 protein which inhibits the host immune 
response by interacting with the components of the in-
terferon (IFN) signaling system [5, 6]. Therefore, LAIVs 
can prevent the formation of an immune response to 
the weakly immunogenic conserved epitopes of influ-
enza proteins and, consequently, suppress the ability of 
the vaccine strain to provide cross-protection against a 
broad range of influenza viruses. The development of ap-
proaches to increase the immunogenicity of conserved 
influenza epitopes can be a promising strategy for cre-
ating a new generation of live influenza vaccines with 
enhanced cross-protection activity. It is known that the 
abrogation of the immunosuppressive activity of NS1 
protein by the truncation of its effector domain increases 
the innate cytokine immune response to influenza virus 
and reduces its reproductive activity in the respiratory 
tract of the host organism [7]. It is also known that im-
munization with live influenza virus with a modified NS 
gene protects mice when challenged with heterologous 
strains of the same virus subtype [8, 9]. 
Previously, we showed that the influenza virus encod-
ing NS1 protein, when shortened to 124 amino acids (aa), 
induced higher proinflammatory cytokine production 
and enhanced innate immune cell stimulation compared 
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to influenza A/PR8/34 wild type virus after the intra-
peritoneal (i.p.) immunization of mice [10]. Here, we in-
vestigate whether the enhanced ability of the influenza 
virus with truncated NS1 protein to activate the innate 
immune system could be translated into a more efficient 
adaptive T-cellular immune response against immuno-
dominant and sub-immunodominant influenza epitopes. 
Since the importance of polyfunctional T-lymphocytes in 
mediating the protective immune response against dif-
ferent bacteria and viruses is well recognized [11–15], we 
analyzed the level and functional activity of the variety 
of T-cells producing IFNγ, IL2, and TNFα. To equalize the 
antigenic load of two viruses with different reproduction 
activity in the respiratory tract of immunized mice, we 
used the i.p. route of immunization, as it was previously 
shown that influenza virus does not replicate in the peri-
toneal cavity but retains the ability to induce a humoral 
and T-cellular immune response [16].  
MATERIALS AND METHODS
Viruses 
Two strains based on the influenza A/Puerto Rico/8/1934 
(H1N1) virus were used for the immunization of mice: 
(1) the virus, encoding full-length NS1 protein (A/PR8/
full NS) and (2) A/PR8/NS124 strain, encoding shortened 
to 124 aa NS1 protein. The strains were obtained by the 
method of reverse genetics [17] assembled in developing 
chicken embryos and purified by fractionation in a su-
crose density gradient according to the standard proce-
dure.
Laboratory animals
This study was performed in C57BL/6 female mice ob-
tained from the Biomedical Science Center (Stolbovaya, 
Russia). All of the experiments with mice in this research 
study were conducted according to the guidelines for 
care and work with laboratory animals [18].
Immunization
The A/PR8/full NS and A/PR8/NS124 viruses were ti-
trated on Vero cells to equalize the immunization dose. 
A limiting dilution assay was performed in 96-well cul-
ture plates (Nunc, Denmark) by the addition of 100 μl of 
prepared dilutions of the virus-containing material in 
OptiPRO SFM (Invitrogen) with 2% L-glutamine (Invit-
rogen) and 5  μg/ml of trypsin (Sigma-Aldrich) into the 
wells and subsequent incubation for 5 days at 34℃ and 
5% CO2. The results were evaluated visually by the es-
timation of the cytopathic effect. Hemagglutination as-
say (using a 0.5% suspension of chicken red blood cells) 
was used as the control. The calculation of virus 50% tis-
sue culture infectious dose (TCID50) was performed us-
ing the Reed and Munch method [19]; the viral titer was 
expressed as log10TCID50/ml. In order to assess the im-
munogenicity of strains, mice were immunized i.p. with 
4.0 or 7.0 log10 TCID50/ml of each virus (500 μl of a virus 
suspension in sodium phosphate buffer (PBS, Biolot)). 
The control group received PBS in an equivalent volume. 
Each group included 5  mice. In total, 45 experimental 
animals were used in the present study.
Flow cytometry
T-cellular immune response was evaluated in splenocytes 
obtained on the 8th and 21st days post-immunization 
(d.p.i.). The spleens were manually homogenized using 
pestle homogenizers (Eppendorf, Germany). Red blood 
cells were lysed using the RBC Lysis Buffer reagent (Bio-
legend, USA). Cells were cultivated in RPMI1640 media 
(Gibco), containing 10% of fetal bovine serum (FBS, Gib-
co) and 1% of penicillin/streptomycin solution (Gibco). 
To stimulate cytokine production, splenocytes were incu-
bated with NP366-374, NP161-175, NP196-210, HA474-483, HA323-337, 
or NA427-433 peptides and brefeldin A (Biolegend) for 6 h at 
37℃ and 5% CO2. Epitopes were selected using the IEDB 
database (www.iedb.org). Peptides were synthesized by 
Verta Ltd. (St. Petersburg, Russia). The sample of each 
peptide (10 mg) was dissolved in DPBS (Biolot, Russia) at 
10 mg/ml and stored in small aliquots at −20℃. The purity 
of the peptides was >90% as determined by high‐perfor-
mance liquid chromatography. After the stimulation, the 
cells were stained with CD8-PE/Cy7, CD4-PerCP-Cy5.5, 
CD44-BV510, CD62L-APC/Cy7, IFNγ-FITC, TNFα-BV421, 
and IL2-PE antibodies using the Fixation and Permeabi-
lization Solution reagent kit (BD Biosciences, USA) ac-
cording to the manufacturer’s instructions. Zombie Red 
viability marker (BioLegend, USA) was used to identify 
the dead cells. True Stain reagent, containing antibodies 
to CD16/CD32, was used to block non-specific antibody 
binding (BioLegend, USA). The data were collected on a 
BD FACSCanto II flow cytometer (BD Biosciences, USA). 
The results were analyzed using the Kaluza Analysis 1.5a 
program (Beckman Coulter, USA). In order to estimate 
the increase in the cytokine production levels upon the 
peptide stimulation, the background values obtained 
from the non-stimulated cells were subtracted from the 
corresponding values of stimulated samples before the 
statistical analysis.  
Statistical analysis
RStudio Desktop 1.0.153 (RStudio Inc, USA) was used 
for statistical data analysis. The Dunnet test was used 
to compare several experimental groups with one con-
trol group. A comparison of two experimental groups 
was carried out using a Student’s t-test. Multiple com-
parisons of several groups were performed using univari-
ate analysis of variance (ANOVA) followed by a pairwise 
comparison of groups using the Tukey criterion. Cellular 
polyfunctionality index (PI) was calculated using the for-
mula: PI = Σ     Fi * (   )ni =1 in  (where n is the number of ana-
lyzed functions (n=3 for IFNγ, IL2, and TNFα) and F is the 
percentage of cells performing i functions) as described 
previously [14, 20]. Integrated mean fluorescence inten-
sity (iMFI) was calculated by multiplying the frequency 
of the particular population by the MFI of IFNγ, IL2, or 
TNFα of this population.
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RESULTS
Selection of epitopes for T-cell immune response 
analysis
The description of the sequence and the conservancy of 
the selected for this study epitopes are shown in Table 1. 
These peptides allowed us to evaluate the effect of NS1 
protein modification on the immunogenicity of the im-
munodominant and sub-immunodominant epitopes 
from the internal (NP) and surface (HA, NA) proteins of 
influenza virus. 
Table 1. T-cell epitopes of influenza virus
Epitope Sequence Conservancy
NP366-374 ASNENMETM 1.8% (63 / 3448)
NP161-175 PRMCSLMQGSTLPRR 98.9% (3411 / 3448)
NP196-210 MIKRGINDRNFWRGE 67.28% (2320 / 3448)
HA323-337 YVKSTKLRLATGLRN 41.9% (4174 / 9949)
HA474-483 KEIGNGCFEF 47.7% (4750 / 9949)
NA427-433 SISFCGV 42.2% (3288 / 7776)
The level of conservancy for each epitope was deter-
mined by calculating the relative number of unique se-
quences of the corresponding protein of influenza A vi-
rus containing a given epitope. The sequences presented 
in the Influenza Research Database were used for the 
conservancy analysis. Data on the immunogenicity of 
epitopes were obtained from publications that compare 
the immune response to different epitopes of the influ-
enza virus [21-26]. 
A/PR8/NS124 mutant virus induces CD8+ response 
at a lower dose of immunization
In order to determine the optimal immunizing dose, 
C57BL/6 mice were injected i.p. with A/PR8/full NS and 
A/PR8/NS124 influenza viruses at a dose of 4.0 and 
7.0 log TCID50/mouse. The antigen-specific T-cellular re-
sponse to immunodominant NP366-374 CD8+ epitope was 
evaluated in spleens 8  d.p.i. Cells were stimulated in 
vitro with this peptide for 6 h after which the levels of 
IFNγ-, IL2-, and TNFα-producing CD8+CD44+CD62L- ef-
fector memory (CD8+ EM) T-cells were estimated by flow 
cytometry. 
The immune response to both strains was dose-depen-
dent. After the immunization of mice with A/PR8/NS124 
at 4.0  log10  TCID50/mouse, 2.88±2.01% of CD8+ effector 
T-lymphocytes produced cytokines in response to 
the in vitro stimulation. On the other hand, after the 
immunization with A/PR8/full NS at the same dose, 
the number of antigen specific cells was 0.34±0.10% 
while in the control group it was 0.26±0.16%. After 
immunization with 7.0 log10 TCID50/mouse of each virus, 
the level of antigen-specific CD8+ EM T-lymphocytes 
was 15.07±2.77% of total CD8+ EM T-cells in the full NS 
group and 26.86±1.72% in the NS124 group (p=0.013, 
Fig.  1). Therefore, A/PR8/NS124 virus was capable of 
inducing CD8+ T-cell response to NP366-374 epitope at a 
lower dose than the influenza strain with the full-length 
NS1 protein and was more immunogenic at a dose that 
induces a substantial immune response to both tested 
viruses. 
The shortening of NS1 protein enhances 
the immunogenicity of sub-immunodominant 
CD8+ T-cell epitopes
Next, we assessed the immunogenicity of sub-immuno-
dominant T-cell epitopes using the highest immunizing 
dose of 7.0  log10  TCID50/mouse. According to Cox et al. 
[15], the peak of CD8+ T-cell response occurs 8-10 days 
after the immunization, followed by a decrease in the 
Fig. 1. CD8+ T-cellular immune response to different doses of A/PR8/full NS or A/PR8/NS124 influenza strains. The total levels of cytokine-
producing effector memory CD8+CD44+CD62L- T-lymphocytes after 6 h of in vitro stimulation of splenocytes of C57BL/6 mice with the 
NP366-374 peptide. Groups were compared using the Student’s t-test (*: p<0.05, n=5).
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number of antigen-specific T-cells. At the same time, 
the spectrum of epitopes inducing adaptive immune re-
sponse shrinks at later stages after immunization [27]. 
Considering these data, we estimated the immune re-
sponse to influenza epitopes on the 8th and 21st days 
after the i.p. immunization. 
Fig.  2 shows the levels of cytokine-producing EM 
(CD44+CD62L-) CD8+ T-cells. Eight days after immuniza-
tion, A/PR8/NS124 virus induced a higher CD8+ T-cell im-
mune response to NP and HA than A/PR8/full NS while 
the immune response to NA protein epitopes was compa-
rable (Fig. 2A). The most pronounced differences in the 
total amount of cytokine-producing cells between full 
NS and NS124 groups were obtained upon stimulation 
with immunodominant NP366-374 epitope. However, stimu-
lation with HA474-483, NA427-433, and NP196-210 peptides, rep-
resenting sub-immunodominant epitopes, also signifi-
cantly increased the immunogenicity of A/PR8/NS124 
virus: for NA427-433 10.7±0.8% of CD8+ EM T-cells in NS124 
group versus 8.4±1.9% in full NS group (p=0.05); for 
HA474-483 9.9±0.9% of CD8+ EM T-cells in NS124 group ver-
sus 7.2±1.8% in full NS group (p=0.03); and for NP196-210 
11.6±1.7% in NS124 group versus 8.3±2.0% in full NS 
group (p=0.05) (Fig. 2A). In vitro stimulation with either 
of the studied epitopes did not result in the induction 
of the significant CD4+ T-cellular response (data not 
shown). 
On the 21st d.p.i., only two epitopes (NP366-374 and 
NA427-433) retained the ability to induce cytokine produc-
tion in CD8+ EM T-cells upon in vitro stimulation in both 
A/PR8/full NS and A/PR8/NS124-immunized groups 
(Fig.2B). The proportion of cytokine-producing T-cells 
was 9.4±1.5% and 14.0±1.3% for NP366-374 and 7.0±0.8% 
and 11.1±2.4% for NA427-433 in full NS and NS124 groups, 
respectively (p=0.003, p=0.01). Therefore, the total CD8+ 
EM T-cellular immune response was higher in the NS124 
group compared to A/PR8/full NS group on the 21st d.p.i. 
The percentage of distinct cytokine-producing popu-
lations of the total amount of CD8+ EM T-cells or of the 
total number of cytokine-producing CD8+ EM T-cells 
on the 8th and 21st d.p.i. in full NS and NS124 groups 
is shown in Fig. 3. Upon stimulation with NP366-374 pep-
tide, the majority of antigen-specific T-cells in both full 
NS and NS124 groups were polyfunctional CD8+ T-cells 
(IFNγ+IL2+TNFα+). The second dominant population of 
antigen-specific T-lymphocytes comprised double cyto-
kine-producers (IFNγ+IL2-TNFα+). The rest (approx. 25% 
of the total cytokine-producing T-cells in both groups) 
was represented by the minor populations of single 
IFNγ-, IL2-, or TNFα-producers or double-positive T-cells 
(IFNγ-IL2+TNFα+ and IFNγ+IL2+TNFα-). The peptides cor-
responding to the sub-immunodominant influenza epit-
opes, as well as NP366-374 epitope, induced a higher level of 
polyfunctional IFNγ+IL2-TNFα+ and IFNγ+IL2+TNFα+ CD8+ 
T-lymphocytes in the NS124 group compared to the full 
NS group on the 8th d.p.i. In contrast to NP366-374 speci-
fic response, all of the evaluated sub-immunodomi nant 
epitopes induced an increased level of IFNγ+IL2-TNFα- 
single-producers in the NS124 group. At the same time, 
A/PR8/full NS strain induced a higher proportion of IFNγ-
IL2-TNFα+ T-cells. The stimulation of CD8+  EM T-cells 
with HA474-483 versus NP161-175 revealed significant differ-
ences between the experimental groups in the amount 
of TNFα single-producers (full NS: 0.8±0.2%, NS124: 
0.4±0.3% (p=0.04) after HA474-483 stimulation; 1.1±0.4%, 
0.7±0.3% (p= 0.05) correspondingly after NP161-175 stimu-
lation).  
The contribution of polyfunctional T-lymphocytes 
(IFNγ+IL2-TNFα+ and IFNγ+IL2+TNFα+) to the cumula-
tive cytokine response increased on the 21st d.p.i. Only 
Fig. 2. T-cellular immune response to different epitopes of influenza virus in the spleens of C57BL/6 mice on 8th (A) and 21th (B) days 
after i.p. immunization with А/PR8/full NS and А/PR8/NS124 influenza strains. Box-plots represent the total levels of cytokine-producing 
CD8+ EM T-lymphocytes after 6 h of in vitro stimulation of splenocytes with peptides corresponding to sub-immunodominant conserva-
tive influenza epitopes. Groups were compared using ANOVA followed by a Tukey’s post-hoc comparison. Significant differences between 
groups (p<0.05, n=5) are marked by *.
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a minor part of the total influenza-specific cells was rep-
resented by IFNγ single producers in both full NS and 
NS124 groups. The IFNγ+IL2+TNFα- CD8+ EM T-cells were 
observed only in A/PR8/NS124-immunized animals. 
A statistically significant difference in the proportion of 
IFNγ+IL2+TNFα+ T-cells was found between the full NS 
and NS124 groups after stimulation with NP366-374 peptide 
(p=0.0003). The immune response to NA427-433 epitope was 
characterized by the formation of the higher amount of 
IFNγ+IL2-TNFα+ and IFNγ+IL2+TNFα+ T-lymphocytes in 
the NS124 group (p=0.02 and p=0.01, respectively). 
Therefore, the immune response to the sub-immuno-
dominant epitopes of A/PR8/NS124 influenza strain was 
characterized by a higher level of total cytokine-produc-
ing T-cells and an increase of the proportion of minor 
IFNγ+IL2+TNFα- population of CD8+ EM T-lymphocytes 
compared to A/PR8/full NS virus on the 8th and 21st 
d.p.i. However, the number of epitopes inducing the CD8+ 
T-cell response simultaneously decreased in both groups 
on the 21st d.p.i.
The A/PR8/NS124 mutant virus promotes 
the appearance of polyfunctional CD8+ lymphocytes 
with enhanced IFNγ expression
In order to estimate the difference in the functional ac-
tivity of cytokine-producing T-cell populations in mice 
upon immunization with A/PR8/full NS or A/PR8/NS124 
viruses, we analyzed the expression levels (mean fluores-
cence intensity, MFI) of IFNγ, IL2, and TNFα in different 
populations of cytokine-producing T-cells on the 8th and 
21st d.p.i. The distribution of CD8+ T-cells from A/PR8/
NS124-immunized mice (8th d.p.i.) by their fluorescence 
intensity of IFNγ, IL2, and TNFα corresponds to their ex-
pression levels as shown in Fig. 4A. The polyfunctional 
Fig. 3. Relative content of different cytokine-producing populations of CD8+ EM T-lymphocytes on the 8th and 21st days after the i.p. im-
munization with А/PR8/full NS and А/PR8/NS124 influenza strains. Radar charts represent the differences in the mean values of epitope-
specific immune response of each population of cytokine-producing CD8+ EM T-cells of immunized mice. Each point is located in the range 
from 0 to the maximal mean value of the corresponding population in full NS or NS124 group. The pie charts represent the percentage 
of cells, producing any combination of IFNγ, IL2, or TNFα cytokines in the total cytokine-producing CD8+ EM T-cell subset. (*: p<0.05, 
Student’s t-test, n=5).
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IFNγ+IL2-TNFα+ and IFNγ+IL2+TNFα+ subpopulations were 
characterized by the highest cytokine-producing activity 
among all antigen-specific T-lymphocytes. In particu-
lar, IFNγ+IL2+TNFα+ triple-producers secreted more IFNγ, 
IL2, and TNFα than their bifunctional or monofunctional 
analogs. IFNγ+IL2-TNFα+ T-cells produced higher levels 
of IFNγ and TNFα than the single-producers express-
ing these cytokines (Fig.  4A). The similar fluorescence 
intensity (FI) distributions were obtained for A/PR8/full 
NS-immunized animals (data not shown). These results 
underline the dominance of polyfunctional T-cells in the 
mediation of CD8+ T-cell cytokine response after i.p. im-
munization regardless of NS1 functionality. 
Nevertheless, the comparison of the full NS and NS124 
groups showed that A/PR8/NS124 virus induced higher 
levels of the IFNγ MFI in IFNγ+IL2-TNFα+ T-cells upon 
the stimulation with NP366-374 peptide (Fig. 4B). Similarly, 
NP161-175, NP196-210, HA323-337, and HA474-483 peptides induced 
higher values of IFNγ MFI in IFNγ+IL2+TNFα+ CD8+ EM 
T-cells in the NS124 group compared to the full NS 
group (p<0.05). No statistically significant differences 
between the experimental groups were found in the 
MFI expression levels of IL2 and TNFα (data not shown). 
The observed differences in the expression level of 
IFNγ in the polyfunctional T-lymphocytes remained 
during 21 days after the immunization. The expression 
level of IFNγ MFI of IFNγ+IL2-TNFα+ was higher in the 
NS124 group compared to the full NS group after the 
stimulation with NP366-374 (p<0.001). The NA427-433 peptide 
induced the enhanced level of the IFNγ MFI in the 
IFNγ+IL2+TNFα+ T-cells in the A/PR8/NS124-immunized 
animals (p=0.02). 
Based on the foregoing data, we can conclude that i.p. 
administration of influenza A/PR8/NS124 virus not only 
stimulates a greater amount of antigen-specific CD8+ 
T-lymphocytes than the A/PR8/full NS strain, but it also 
ensures the formation of polyfunctional T-cells with the 
enhanced IFNγ -producing activity.
Fig. 4. IFNγ expression level in IFNγ+IL2-TNFα+ and IFNγ+IL2+TNFα+ cytokine-producing populations of CD8+ EM T-lymphocytes on 8th and 
21st days after the i.p. immunization with А/PR8/full NS and А/PR8/NS124 influenza strains. (A) The distribution of fluorescence intensity 
of cytokine-producing cells from mice immunized with 7.0 log TCID50/mouse of the A/PR8/NS124 influenza strain. The density plots repre-
sent the differences in the cytokine expression level between the subsets of cytokine-producing cells. (B) IFNγ mean fluorescence intensity 
(MFI) values of the polyfunctional subpopulations after peptide stimulation were compared using the Student’s t-test (*: p<0.05, n=5).
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DISCUSSION
CD8 T-cell immune response to conserved antigens is 
essential for cross-protection against a broad variety of 
influenza viruses [3, 28]. T-lymphocytes recognize the 
linear (8-24  aa) epitopes of the internal influenza an-
tigens [29, 30]. Unfortunately, the majority of the con-
served influenza epitopes maintain low immunogenicity 
during the course of natural influenza infection and vac-
cination. Therefore, the development of new approaches 
for vaccination that will ensure cell-mediating immune 
responses is of great importance.  
Adaptive T-cell immune response is strongly de-
pendent on the cytokine milieu and activated antigen-
presenting cells generated during the innate immune 
response. Previously, we showed that A/PR8/NS124 in-
fluenza virus injected i.p. induces the production of IFNβ 
at a 300 times higher level than the virus expressing full-
length NS1 protein in the peritoneal washes as well as 
promotes the increased expression of co-stimulatory 
CD86-molecules participating in the T-cell differentia-
tion process [10]. In this study, we estimated the effect 
of the modification of the NS1 protein on the immuno-
genicity of the immunodominant and sub-immunodom-
inant epitopes of the internal and surface proteins of the 
influenza virus. It was shown that the lower immuniza-
tion dose of A/PR8/NS124 is required for triggering the 
CD8+ response compared to NS1 competent virus. In ad-
dition, the NS1 mutant virus induced the formation of 
an increased number of antigen-specific effector CD8+ 
T -lymphocytes compared to the A/PR8/full NS strain at 
the highest immunization dose. The shortening of the 
NS1 protein resulted in the simultaneous enhancement 
of the immunogenicity of all the studied epitopes. This 
was reflected in the increased formation of polyfunc-
tional CD8+ IFNγ+IL2-TNFα+ and IFNγ+IL2+TNFα+ T-lym-
phocytes and monofunctional IFNγ+IL2-TNFα- T-cells in 
mice immunized with A/PR8/NS124. Antigen-specific 
polyfunctional T-cells play a key role in providing pro-
tection against reinfection with different microbial and 
viral pathogens [11, 12, 31-34]. It is known that polyfunc-
tional T-lymphocytes have a prolonged life cycle com-
pared to monofunctional subpopulations and serve as a 
source for the formation of long-lived memory cells [33]. 
Polyfunctional T-lymphocytes also provide a significant 
contribution to the formation of the immune response to 
conserved influenza antigens and could be considered as 
effectors for cross-protection against antigenically diver-
gent influenza viruses [34]. In the course of this research 
project, we only analyzed the cytokine-producing func-
tion of T-lymphocytes. However, from previous studies, 
it is known that the polyfunctional T-cells demonstrate 
more efficient killing capacities compared to their mono-
functional analogs [35-38]. Therefore, we can speculate 
that influenza virus-specific polyfunctional T-cells gen-
erated in response to the A/PR8/NS124 immunization 
may be characterized by higher cytotoxic activity com-
pared to the T-lymphocytes formed after the immuniza-
tion with A/PR8/full NS strain. This hypothesis deserves 
further evaluation. 
The published data on the role of TLR7/8 and RIG-I 
signaling pathways in the activation of dendritic cells 
as well as the induction of T-lymphocytes maturation 
could be used for the explanation of the increased po-
tency of A/PR8/NS124 virus in the induction of poly-
functional T-cells. Mice with impaired RIG-I expres-
sion are characterized by the formation of the reduced 
number of polyfunctional T-lymphocytes in response 
to the immunization and weakened protection against 
heterologous strains of the influenza virus [39]. Consid-
ering that NS1 protein mediates its immunosuppressive 
function through direct interaction with RIG-I, it should 
be expected that the immunization of mice with influ-
enza virus lacking the effector domain of NS1 protein 
would lead to the enhanced production of the polyfunc-
tional T-lymphocytes. We found that IFNγ+IL2-TNFα+ 
and IFNγ+IL2+TNFα+ T-cells generated after immuniza-
tion with the A/PR8/NS124 strain produced a higher 
amount of IFNγ compared to A/PR8/full NS-immunized 
mice. To compare the cumulative functional properties 
of influenza-specific T-cell immune response to A/PR8/
full NS and A/PR8/NS124 strains after the i.p. immuni-
zation, we calculated an integrated MFI (iMFI) of IFNγ 
in predominant polyfunctional populations and cellular 
polyfunctionality index (PI) for each observation as was 
described previously [14, 20]. The results are presented 
in Supplementary Tables 2S and 3S. PI and iMFI reflect 
both the magnitude and quality of immune response. 
The higher values of these two parameters in the NS124 
group compared to full NS group after the stimulation 
with HA474-483, HA323-337, NP366-374, and NP196-210 on the 8th 
d.p.i. and with NP366-374 and NA427-433 on the 21st d.p.i. 
showed that the shortening of NS1 protein leads to the 
increase in both the magnitude of T-cell immune re-
sponse to influenza virus and the functional activity of 
antigen-specific T-lymphocytes. Since the goal of the 
present study was to compare the immunogenicity of 
the two viruses with different reproduction activity in 
the respiratory system, we analyzed only the systemic 
immune response to A/PR8/full NS and A/PR8/NS124 
viruses after the i.p. immunization. However, growing 
literature evidence proves the importance of the local 
immune response to the influenza virus in the lung tis-
sue for the mediation of heterologous protection. It was 
shown that the populations of CD69+CD103+ tissue resi-
dent memory CD4+ and CD8+ T-cells (Trm) play a critical 
role in local immune protection by means of the direct 
killing of infected cells [40, 41] and cytokine release [42], 
promoting the recruitment of the immune cells from 
the circulation and switching the state of the surround-
ing cells to non-permissive [43]. Trms are indispensable 
for providing optimal heterosubtypic immunity [44, 45]. 
Therefore, the vaccines that induce the formation of in-
fluenza virus-specific Trm cells in the lungs provide su-
perior protection against heterologous influenza strains 
[46, 47]. Moreover, as it was shown by Zhao et al., Trm 
generated in lungs after intranasal vaccine administra-
tion were more protective against challenge with patho-
genic human coronaviruses than those generated after 
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systemic vaccination [48]. Given the obtained data, we 
could expect that live attenuated vaccines based on vi-
ruses with shortened NS1 protein will have higher po-
tential in the induction of cross-reactive Trm compared 
to the existing LAIVs. 
It should be noted that the inhibition of the immuno-
suppressive function of the NS1 protein did not prevent 
the loss of immunogenicity of several sub-immunodom-
inant epitopes of influenza virus on the 21st d.p.i. The 
importance of the conserved low immunogenic epitopes 
for the formation of a cross-protective immune response 
is well known [3]. Therefore, the influenza viruses with 
the shortened NS1 protein could be considered as a tool 
for the creation of influenza virus vectors overexpress-
ing important cross-protective epitope sequences from 
various genomic fragments. Such a strategy for vaccine 
development might solve the problem of losing the im-
munogenicity of conserved subdominant epitopes at the 
later stages after immunization. 
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